Documente Academic
Documente Profesional
Documente Cultură
ScienceDirect
journal homepage: www.elsevier.com/locate/etap
Biochemistry Department, Centro de Investigacin y Estudios Avanzados IPN, Mxico, DF, Mexico
CIATEC, Len, GTO, Mexico
c Faculty of Medicine, UJED, Durango, DGO, Mexico
d Section of Methodology of Science, Centro de Investigacin y Estudios Avanzados IPN, Mxico, DF, Mexico
e HRAEB, Len, GTO, Mexico
f Cellular Physiology Institute, UNAM, Mexico
b
a r t i c l e
i n f o
a b s t r a c t
Article history:
The molecular response of the antioxidant system and the effects of antioxidant supplemen-
tation against oxidative insult in lead-exposed workers has not been sufciently studied. In
this work, antioxidants (vitamin E 400 IU + vitamin C 1 g/daily) were supplemented for one
3 October 2013
year to 15 workers exposed to lead (73 g of lead/dl of blood) and the results were com-
pared with those on 19 non-lead exposed workers (6.7 g of lead/dl). Lead intoxication was
Keywords:
plementations decreased signicantly the oxidative damage as well as the total antioxidant
Antioxidants
capacity induced by lead intoxication with reduction of the antioxidant enzyme activities.
response due to increased activity of catalase and superoxide dismutase. Antioxidant sup-
Oxidation
Blood
Human
lead-exposed workers.
Lead toxicity
Enzymes
1.
Introduction
Lead is one of the metals most commonly used in industry; its toxicity is a public health problem due mainly to its
environmental persistence, inadequate labor security conditions and low lead excretion in lead-exposed workers (Nilsson
Corresponding author at: Biochemistry Department, Centro de Investigacin y Estudios Avanzados IPN, Mxico DF. Av. IPN 2508, Zacatenco, Mxico 07000, DF AP 14-740, Mexico. Tel.: +52 55 57473955.
E-mail address: jcalder@cinvestav.mx (J.-V. Caldern-Salinas).
1382-6689/$ see front matter 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.etap.2013.10.016
46
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
2.
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
2.1.
Lead concentration in blood was determined with a Lead Analyzer, model 3010B (ESA), as previously described (QuintanarEscorza et al., 2007). Concentration is reported in micrograms
per deciliter of blood. Lead determinations were run in triplicates. The standard curves were calculated with the method
of addition to minimize the matrix effect on the absorption
peak (recovery of 85113%). Precision of analyses was around
87104% (using ESA Hi and Lo calibrators) and the detection
limit set at 1 g/dl.
2.2.
-ALAD activity
-ALAD activity in erythrocytes was determined spectrophotometrically (US/VIS DU 650) (Beckman) and expressed as
nanomol of porphobilinogen (PBG) per milliliter of erythrocytes per hour (nmol/ml/h) (Rendn-Ramrez et al., 2007).
2.3.
Vitamins E and C
Serum tocoferol and ascorbate were determined by highperformance liquid chromatography in a single chromatographic run with an internal standard (Merzouk et al., 2003;
Lenton et al., 2003).
2.4.
2.7.
2.8.
2.9.
Erythrocytes TAC
2.6.
Lipid peroxidation
2.5.
47
CAT activity was determined in erythrocytes by spectrophotometry and is expressed in U/mg protein. This method
measures the exponential disappearance of H2 O2 (3 mM) at
240 nm in presence of cellular homogenates (5 Hb/dl) with
2.10.
Statistical analysis
48
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
Table 1 Number of individuals presenting clinical symptoms and signs associated to lead intoxication in lead and
non-lead exposed workers.
Lead exposed
(n = 15)
Non-lead exposed
(n = 19)
Dizziness
Headache
Paresthesia
Paresis
Abdominal colic
Myalgia
Motor coordination alteration
7*
11*
6*
3*
5*
8*
14*
1
3
1
0
2
2
1
46.6 (2173)
73.3 (4592)
40.0 (1668)
20.0 (448)
33.3 (1262)
53.3 (2779)
93.3 (68100)
Signicant difference (P 0.05) between lead and non-lead exposed workers, according to X2 test. In the third column, percent (lower 95% CI
upper 95% CI) of individuals with a sign or symptom in the lead-exposed group, assuming binomial distribution, exact method, computed
following (Blair and Taylor, 2008).
Table 2 Biological indices (mean SD) of lead intoxication in blood of non-lead exposed and lead exposed workers.
Non-lead exposed (n = 19)
6.7 2.2
683 61
PbB (g/dl)
-ALAD activity (nmol PBG/h/ml)
Difference between
means SD
73 11
138 34
65.8 2.5***
545 17.6***
p < 0.0001.
3.
Results
3.1.
symptom goes from 0.38 to 0.64 ( = 0.05, df = 6, Pearsons Chisquare test). Blood lead concentration was higher in lead
exposed with respect to non-lead exposed workers (P < 0.0001)
indicative of a chronic and signicant lead exposure. Erythrocyte -ALAD activity was signicantly lower in lead exposed
than in non-lead-exposed workers (P < 0.0001) also suggesting
a severe chronic lead intoxication (Table 2). The oxidative damage (lipid peroxidation) and TAC in erythrocytes were higher
in lead exposed with respect to non-lead exposed workers
(P < 0.0001 and P < 0.0001, respectively) denoting an oxidative stress characterized by an increase in the antioxidant
response, but not enough to contain oxidative insult (Table 3).
A major enzymatic antioxidant response was present in lead
exposed workers, as both CAT and SOD activities in erythrocytes were much higher in this group than in the control
group (P < 0.0001 and P < 0.0001, respectively). However, lower
Table 3 Lipid peroxidation and antioxidant defense system status at the beginning of vitamin E/vitamin C
supplementation. Thiobarbituric acid reactive species concentration (TBARS), total antioxidant capacity (TAC), CAT
activity, SOD activity, GPx activity, GRx activity and serum concentration of vitamins E and C, in blood of non-lead
exposed and lead exposed workers (mean SD).
Difference between
means SD
0.7 0.2
66 3.7
1.3 0.4
110 8.1
0.57 0.01***
44.4 2.08***
11
209
12
9.7
1.5
45
1.8
2.2
24 5.4
69 9.5
37
534
10
3.1
7.5*
55*
2.2
1.2*
22 4.3
72 7.8
26.0
324
2.0
6.6
1.8***
17.1***
0.7**
0.6***
1.1 1.7
3.7 3.0
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
3.2.
49
4.
Discussion
Lead exposed workers presented very high blood lead concentration and -ALAD activity severely inhibited, which
indicates that these workers had been extensively exposed
to lead. Additionally, they showed clinical symptoms and
signs frequently associated to lead intoxication (CaldernSalinas et al., 1996; Levin and Goldberg, 2000; Patrick, 2006a;
Quintanar-Escorza et al., 2007). They also presented elevated
oxidative damage, similar to that described in other lead exposure populations (Gurer-Orhan et al., 2004; Quintanar-Escorza
et al., 2007; Costa et al., 1997; Flajs et al., 2009) (Fig. 3).
The lead-exposed group showed an adaptive response
to oxidative insult high TAC due to lead intoxication;
50
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
Table 4 Effects of vitamin E/vitamin C supplementation on levels of biological indices of lead intoxication in blood of
non-lead exposed and lead exposed workers. Blood lead concentration (PbB) and -aminolevulinic acid dehydratase
activity (-ALAD), before and after supplementation (mean SD).
Non-lead exposed (n = 19)
PbB (g/dl)
-ALAD activity
(nmolPBG/h/ml)
Before
After
6.7 2.2
683 61
7.1 1.6
696 54
Before
73 11
138 34
0.81.0
1.01.04
After
70 9.1
315 38
0.91.0*
2.02.8***
Table 5 Effect of vitamin E/vitamin C supplementation on the antioxidant status in blood of non-lead exposed and lead
exposed workers: GPx activity, GRx activity, serum vitamin E concentration, serum vitamin C concentration in blood of
lead and non-lead exposed workers. Values are mean SD.
Non-lead exposed (n = 19)
Before
Serum vitamin E
(mol/ml)
Serum vitamin C
(mol/l)
GPx activity (U/g
Hb)
GRx activity (U/g
Hb)
After
Before
After
24 5.4
52 5.0
2.02.5***
22 4.3
26 5.1
1.11.2***
69 9.5
106 9.8
1.41.7***
72 7.8
88 7.7
1.11.3***
12 1.8
14 1.3
1.11.3**
10 2.2
10 2.1
0.91.1
9.7 2.2
11 2.1
1.01.2
3.1 1.2
3.8 1.0
1.01.5*
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
51
52
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
Acknowledgments
The authors thank Rosas Margarita, Camacho Hctor and Ruiz
Antonio for technical assistance.
references
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
53
54
e n v i r o n m e n t a l t o x i c o l o g y a n d p h a r m a c o l o g y 3 7 ( 2 0 1 4 ) 4554
Ye, X.B., Fu, H., Zhu, J.L., Ni, W.M., Lu, Y.W., Kuang, X.Y., Yang, S.L.,
Shu, B.X., 1999. A study on oxidative stress in lead-exposed
workers. J. Toxicol. Environ. Health A 57,
161172.
Yin, S.T., Tang, M.L., Su, L., 2008. Effects of
epigallocatechin-3-gallate on lead-induced oxidative damage.
Toxicology 249, 4554.